Pathogenesis ACS

  • Upload
    way-lee

  • View
    219

  • Download
    0

Embed Size (px)

Citation preview

  • 7/27/2019 Pathogenesis ACS

    1/32

    Presenter: Dr LiuSupervisor: Dr Nik Arif

    PATHOGENESIS OF ACS

  • 7/27/2019 Pathogenesis ACS

    2/32

    INTRODUCTION

    Acute coronary syndrome is a clinical

    spectrum of ischemic heart disease

    ranging from unstable angina, NSTEMI to

    STEMI depending upon the degree and

    acuteness of coronary occlusion

    Coronary artery disease (CAD) is the

    nations leading cause of death.

  • 7/27/2019 Pathogenesis ACS

    3/32

    TERMINOLOGY

    Arteriosclerosis

    -thickened and stiffened arteries of all sizes

    Atherosclerosis

    -is the descriptive term for thickened and

    hardened lesion of the medium and large

    muscular and elastic arteries

    Atherothrombosis

    -atherosclerotic plaque with superimposed

    thrombosis

  • 7/27/2019 Pathogenesis ACS

    4/32

    Causes of coronary artery disease.

    Type CommentsAtherosclerosis Most common cause. Risk factors include hypertension,

    hypercholesterolemia, diabetes mellitus, smoking, and a

    family history of atherosclerosis.

    Spasm Coronary artery vasospasm can occur in any population but

    is most prevalent in Japanese. Vasoconstriction appears tobe mediated by histamine, serotonin, catecholamines, and

    endothelium-derived factors. Because spasm can occur at

    any time, the chest pain is often not exertion-related.

    Emboli Rare cause of coronary artery disease. Can occur from

    vegetations in patients with endocarditis.

    Congenital Congenital coronary artery abnormalities are present in 2%

    of the population. However, only a small fraction of these

    abnormalities cause symptomatic ischemia.

  • 7/27/2019 Pathogenesis ACS

    5/32

    PATHOGENESIS OF ACS

    The arterial lumen must be decreased by90% to produce cellular ischemia when the

    patient is at rest.

    With exercise, a 50% reduction in lumen sizecan lead to symptoms

  • 7/27/2019 Pathogenesis ACS

    6/32

    Platelet release of vasoconstrictive factors

    such as thromboxane A2 or serotonin and

    endothelial dysfunction may cause

    vasoconstriction and contribute todecreased flow.

  • 7/27/2019 Pathogenesis ACS

    7/32

    Normal artery

  • 7/27/2019 Pathogenesis ACS

    8/32

    Progression of human coronary atherosclerotic

    plaque.

  • 7/27/2019 Pathogenesis ACS

    9/32

    1. Normal artery

  • 7/27/2019 Pathogenesis ACS

    10/32

    2.-Endothelial cells injury,

    activated by risk factors such asDyslipidaemia, Hypertension,

    Smoking, DM

    -recruit inflammatory leukocytes

    such as monocytes and T

    lymphocytes.

    -Extracellular lipid begins to

    accumulate in intima at thisstage.

  • 7/27/2019 Pathogenesis ACS

    11/32

    3. -Monocytes become macrophages

    -Macrophages engulfing modified

    lipoproteins become foam cells.-Leukocytes and resident vascular

    wall cells secrete inflammatory

    cytokines and growth factors that

    amplify leukocyte recruitment and

    cause smooth muscle cell migration

    and proliferation.

  • 7/27/2019 Pathogenesis ACS

    12/32

    Dyslipidaemia, Hypertension, Smoking, DM

    Endothelial injury

    Recruitment of monocyte and T-lymphocyte to vessel wall

    Activated macrophage

    Engulf oxidised LDL

    Foam cells

    Accumulation of foam cells to form fatty streak

    Release of various cytokines

    Smooth muscle migration from t.media to intima (lay down collagen)

    Smooth muscle proliferate and produce extracellular matrix

    Forming a fibrous cap

  • 7/27/2019 Pathogenesis ACS

    13/32

    4. As lesion progresses,

    inflammatory mediators cause

    expression of tissue factor, a

    potent procoagulant, and of

    matrix-degrading proteinasesthat weaken fibrous cap of

    plaque.

  • 7/27/2019 Pathogenesis ACS

    14/32

    5. If fibrous cap ruptured, causing

    thrombosis on nonocclusiveatherosclerotic plaque.

    -If balance between prothrombotic

    and fibrinolytic unfavorable,

    occlusive thrombus causing acutecoronary syndromes may result.

  • 7/27/2019 Pathogenesis ACS

    15/32

    6. When thrombus resorbs, productsassociated with thrombosis such as

    thrombin and mediators released fromdegranulating platelets can cause healing

    response, leading to increased collagen

    accumulation and smooth muscle cell

    growth.-In this manner, the fibrofatty lesion can

    evolve into advanced fibrous and often

    calcified plaque, one that may cause

    significant stenosis, and producesymptoms of stable angina pectoris.

  • 7/27/2019 Pathogenesis ACS

    16/32

    7. In some cases, occlusive thrombi

    arise not from fracture of fibrous

    cap but from superficial erosion ofendothelial layer. Resulting mural

    thrombus, again dependent on

    local prothrombotic and fibrinolytic

    balance, can cause acutemyocardial infarction.

  • 7/27/2019 Pathogenesis ACS

    17/32

    Plaque rupture

    Intraplaque

    hemorrhage

    Tissue factor

    releasedSubendothelial collagen

    exposure

    Lumennarrowing

    Coagulation cascade

    activation

    Coronary

    thrombus

    Platelet

    adhesion,

    activation

    Platelet

    aggregation

    Reduced

    vasodilator

    effect

    Vasoconstriction

    Antithrombic

    effect

    Dysfunctional

    endothelium

    Artherosclerosis

  • 7/27/2019 Pathogenesis ACS

    18/32

  • 7/27/2019 Pathogenesis ACS

    19/32

    http://www.google.com/url?sa=i&rct=j&q=mechanism+platelet+aggregation&source=images&cd=&cad=rja&docid=NrgWmo4jZ2XIZM&tbnid=-80jlv6HVLxzYM:&ved=0CAUQjRw&url=http%3A%2F%2Fwww.medscape.org%2Fviewarticle%2F582623&ei=TdfcUZjXDs2CrgfC6YHwAg&psig=AFQjCNF1RLbrHPLgeh4RtWgWiyKVbDoxxw&ust=1373513843764628
  • 7/27/2019 Pathogenesis ACS

    20/32

    The role of lipid in artherosclerosis

    directly impair endothelial cell function

    through increase production of free

    radicals.

    Lipoproteins accumulate within the intima

    at sites of increase endothelial

    permeability

    Chemical changes of lipid induced by free

    radicals yield oxidized LDL

  • 7/27/2019 Pathogenesis ACS

    21/32

    Oxidized LDL

    i) Ingested by macrophages to form foam

    cells

    ii) Increases monocytes accumulation in

    lesions

    iii) Stimulates release of growth factors and

    cytokines

    iv) Induce endothelial cell dysfunction

  • 7/27/2019 Pathogenesis ACS

    22/32

    Role of macrophages

    Adhere to endothelium

    Migrate btwn ECs to localize in the intima

    Engulf lipoproteins, largely oxidized LDL tobecome foam cells

  • 7/27/2019 Pathogenesis ACS

    23/32

    Role of SMC proliferation

    Convert a fatty streak into a mature

    fibrofatty atheroma and contribute to the

    progressive growth of atherosclerotic

    lesions

  • 7/27/2019 Pathogenesis ACS

    24/32

  • 7/27/2019 Pathogenesis ACS

    25/32

    PATHOPHYSIOLOGY

    CHEST PAIN

    SHOCK

    BRADYCARDIA NAUSEA/VOMITING

    TACHYCARDIA

  • 7/27/2019 Pathogenesis ACS

    26/32

    Chest pain

    Traditionally due to ischemia.

    70-80% are asymptomatic.

    Mediated by sympathetic afferent fibersthat richly innervate the atrium and

    ventricle.

    Trigger for nerve stimulation- adenosine

  • 7/27/2019 Pathogenesis ACS

    27/32

    Factors for asymptomatic :

    1) dysfunction of afferent nerves,

    2) transient reduced perfusion, and3) differing pain thresholds

  • 7/27/2019 Pathogenesis ACS

    28/32

    SHOCK

    Cardiac failure- obstruction of the left main

    coronary or LAD artery.

    Myocardial rupture

    Pericardial effusion and tamponade

    Rupture of the papillary muscles

  • 7/27/2019 Pathogenesis ACS

    29/32

    BRADYCARDIA

    a/w inferior MI- occlusion of the right

    coronary artery

  • 7/27/2019 Pathogenesis ACS

    30/32

    NAUSEA AND VOMITING

    Activation of the vagus nerve

  • 7/27/2019 Pathogenesis ACS

    31/32

    TACHYCARDIA

    Raised catecholamines to maintain stroke

    volume

  • 7/27/2019 Pathogenesis ACS

    32/32

    THANK YOU